Literature DB >> 2859044

Side-effects of beta-adrenoceptor blocking drugs assessed by visual analogue scales.

R V Lewis, P R Jackson, L E Ramsay.   

Abstract

A series of visual analogue scales (VAS) was used to examine the prevalence of side-effects among hypertensive patients taking beta-adrenoceptor blocking drugs. When compared to untreated non-hypertensive control subjects, patients taking beta-adrenoceptor blockers had a greater prevalence of tired legs (P less than 0.001), cold digits (P less than 0.01), insomnia (P less than 0.01) and loss of overall wellbeing (P less than 0.01). Side-effects did not differ significantly between patients taking atenolol (n = 30), oxprenolol (n = 16), propranolol (n = 15) or metoprolol (n = 10). If there is an important difference in the prevalence of side-effects between different beta-adrenoceptor blockers, a much larger study will be needed to demonstrate it.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859044      PMCID: PMC1463712          DOI: 10.1111/j.1365-2125.1985.tb02639.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  3 in total

1.  A symptom questionnaire for hypertensive patients.

Authors:  C J Bulpitt; C T Dollery; S Carne
Journal:  J Chronic Dis       Date:  1974-08

2.  Quantification of side-effects of beta-adrenoceptor blockers using visual analogue scales.

Authors:  R V Lewis; P R Jackson; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

Review 3.  Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions.

Authors:  M J Kendall; L Beeley
Journal:  Pharmacol Ther       Date:  1983       Impact factor: 12.310

  3 in total
  6 in total

1.  Influence of debrisoquine oxidation phenotype on exercise tolerance and subjective fatigue after metoprolol and atenolol in healthy subjects.

Authors:  R V Lewis; L E Ramsay; P R Jackson; W W Yeo; M S Lennard; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

2.  Documentation of an instrument for assessment of subjective CNS-related symptoms during cardiovascular pharmacotherapy.

Authors:  C Dahlöf; E Dimenäs; B Olofsson
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

Review 3.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

4.  Measuring side-effects of beta-adrenoceptor antagonists: a comparison of two methods.

Authors:  R V Lewis; P R Jackson; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

Review 5.  Pharmacokinetics of long acting propranolol. Implications for therapeutic use.

Authors:  G S Nace; A J Wood
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

6.  beta blockade and intermittent claudication: placebo controlled trial of atenolol and nifedipine and their combination.

Authors:  S A Solomon; L E Ramsay; W W Yeo; L Parnell; W Morris-Jones
Journal:  BMJ       Date:  1991-11-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.